The report includes the following appendices:
MIRD-237 represents a comprehensive effort to collate and evaluate the dosimetry data for a wide range of radiopharmaceuticals. This report is not only a valuable resource for nuclear medicine professionals but also serves as a guide for researchers and clinicians involved in the development, application, and regulation of radiopharmaceuticals. MIRD-237
: Accurate dosimetry helps in minimizing the risk of radiation exposure to patients while maximizing the therapeutic effect of radiopharmaceuticals. This balance is crucial for the treatment of various diseases, including cancer. This balance is crucial for the treatment of
Advances in nuclear technology and the development of new production methods have made it possible to produce the MIRD-237 on a large scale. Today, the isotope is produced through the irradiation of Ytterbium-176 with neutrons in a nuclear reactor or through the proton bombardment of Ytterbium-176 in a particle accelerator. MIRD-237
The report includes the following appendices:
MIRD-237 represents a comprehensive effort to collate and evaluate the dosimetry data for a wide range of radiopharmaceuticals. This report is not only a valuable resource for nuclear medicine professionals but also serves as a guide for researchers and clinicians involved in the development, application, and regulation of radiopharmaceuticals.
: Accurate dosimetry helps in minimizing the risk of radiation exposure to patients while maximizing the therapeutic effect of radiopharmaceuticals. This balance is crucial for the treatment of various diseases, including cancer.
Advances in nuclear technology and the development of new production methods have made it possible to produce the MIRD-237 on a large scale. Today, the isotope is produced through the irradiation of Ytterbium-176 with neutrons in a nuclear reactor or through the proton bombardment of Ytterbium-176 in a particle accelerator.